BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2686818)

  • 1. More on 'head and neck radiation therapy'.
    Epstein JB; Stevenson-Moore P
    J Can Dent Assoc; 1989 Dec; 55(12):960. PubMed ID: 2686818
    [No Abstract]   [Full Text] [Related]  

  • 2. Dental care for the irradiated cancer patient.
    Ritchie JR; Brown JR; Guerra LR; Mason G
    Quintessence Int; 1985 Dec; 16(12):837-42. PubMed ID: 2938208
    [No Abstract]   [Full Text] [Related]  

  • 3. Using technology to decrease xerostomia for head and neck cancer patients treated with radiation therapy.
    Amosson CM; Teh BS; Mai WY; Woo SY; Chiu JK; Donovan DT; Parke R; Carpenter LS; Lu HH; Grant WH; Butler EB
    Semin Oncol; 2002 Dec; 29(6 Suppl 19):71-9. PubMed ID: 12577249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managing complications of radiation therapy in head and neck cancer patients: Part VI. Management of opportunistic infections.
    Ngeow WC; Chai WL; Ramli R; Rahman RA
    Singapore Dent J; 2006 Dec; 28(1):19-21. PubMed ID: 17378338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of Cepharanthin to prevent radiation induced xerostomia in head and neck cancer].
    Imada H; Nomoto S; Ohguri T; Yahara K; Kato F; Morioka T; Korogi Y
    Gan To Kagaku Ryoho; 2004 Jul; 31(7):1041-5. PubMed ID: 15272582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of pilocarpine during radiation therapy: results of RTOG 97-09, a phase III randomized study in head and neck cancer patients.
    Scarantino C; LeVeque F; Swann RS; White R; Schulsinger A; Hodson DI; Meredith R; Foote R; Brachman D; Lee N
    J Support Oncol; 2006 May; 4(5):252-8. PubMed ID: 16724649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized double blind, placebo-controlled study of pilocarpine administered during head and neck irradiation to reduce xerostomia.
    Sangthawan D; Watthanaarpornchai S; Phungrassami T
    J Med Assoc Thai; 2001 Feb; 84(2):195-203. PubMed ID: 11336078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxicity and compliance of subcutaneous amifostine in patients undergoing postoperative intensity-modulated radiation therapy for head and neck cancer.
    Thorstad WL; Chao KS; Haughey B
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):8-12. PubMed ID: 15726516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation, prevention and management of radiotherapy-induced xerostomia in head and neck cancer patients.
    de Castro G; Federico MH
    Curr Opin Oncol; 2006 May; 18(3):266-70. PubMed ID: 16552239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managing complications of radiation therapy in head and neck cancer patients: Part I. Management of xerostomia.
    Ngeow WC; Chai WL; Rahman RA; Ramli R
    Singapore Dent J; 2006 Dec; 28(1):1-3. PubMed ID: 17378333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventing radiation induced xerostomia.
    Koukourakis MI; Danielidis V
    Cancer Treat Rev; 2005 Nov; 31(7):546-54. PubMed ID: 16257125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensity-modulated radiation therapy and xerostomia.
    Chambers MS; Weber RS; Garden AS
    J Calif Dent Assoc; 2006 Sep; 34(9):743-8. PubMed ID: 17022299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II trial of subcutaneous amifostine in patients undergoing radiation therapy for head and neck cancer.
    Anné PR
    Semin Oncol; 2002 Dec; 29(6 Suppl 19):80-3. PubMed ID: 12577250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of saliva in oral health: strategies for prevention and management of xerostomia.
    Brosky ME
    J Support Oncol; 2007 May; 5(5):215-25. PubMed ID: 17564151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of amifostine to prevent xerostomia in patients receiving radiation therapy.
    Batcha M
    Oncol Nurs Forum; 2000 May; 27(4):615-6. PubMed ID: 10833684
    [No Abstract]   [Full Text] [Related]  

  • 16. [Oral hygiene in radiation patients. Evaluation of the effect of oral hygiene measures in the treatment of mucositis of the oral mucosa during radiation therapy].
    Spijkervet FK; Boering G; Panders AK; Vermey A; Dun JA; Menta DM; Zwart J
    Ned Tijdschr Tandheelkd; 1985 Mar; 92(3):85-8. PubMed ID: 3858698
    [No Abstract]   [Full Text] [Related]  

  • 17. Pilocarpine in the prevention of postirradiation xerostomia.
    Lajtman Z; Krajina Z; Krpan D; Vincelj J; Borcić V; Popović-Kovacić J
    Acta Med Croatica; 2000; 54(2):65-7. PubMed ID: 11028111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managing complications of radiation therapy in head and neck cancer patients: Part III. Provision of dentures.
    Rahman RA; Ngeow WC; Chai WL; Ramli R
    Singapore Dent J; 2006 Dec; 28(1):7-10. PubMed ID: 17378335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dental management of patients undergoing radiation therapy for cancer of the head and neck.
    Miller EC; Vergo TJ; Feldman MI
    Compend Contin Educ Dent (Lawrenceville); 1981; 2(6):350-6. PubMed ID: 6950869
    [No Abstract]   [Full Text] [Related]  

  • 20. Radiotherapy for head and neck neoplasms.
    Whitmyer CC; Esposito SJ; Terezhalmy GT
    Gen Dent; 1997; 45(4):363-70; quiz 377-8. PubMed ID: 9515444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.